Cytokinetics, Incorporated

CYTK · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$94,857$113,024$65,582$112,666
Short-Term Investments$981,157$501,800$716,995$358,972
Receivables$16,650$1,283$147$51,819
Inventory$0$0$0$0
Other Curr. Assets$15,276$11,944$12,462$12,215
Total Curr. Assets$1,107,940$628,051$795,186$535,672
Property Plant & Equip (Net)$140,973$147,735$163,190$146,409
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$145,055$40,534$46,708$152,050
Tax Assets$0$0$0$0
Other NC Assets$7,705$7,996$9,691$7,188
Total NC Assets$293,733$196,265$219,589$305,647
Other Assets$0$0$0$0
Total Assets$1,401,673$824,316$1,014,775$841,319
Liabilities
Payables$20,369$21,507$25,611$21,087
Short-Term Debt$30,498$27,971$13,787$14,863
Tax Payable$0$0$0$0
Deferred Revenue$52,370$0$0$0
Other Curr. Liab.$76,437$53,200$45,219$35,910
Total Curr. Liab.$179,674$102,678$84,617$71,860
LT Debt$758,179$727,800$736,513$255,067
Deferred Rev, NC$0$0$0$87,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$599,192$380,161$301,545$183,529
Total NC Liab.$1,357,371$1,107,961$1,038,058$525,596
Other Liabilities$0$0$0$0
Cap. Leases$131,560$138,318$139,724$127,092
Total Liabilities$1,537,045$1,210,639$1,122,675$597,456
Equity
Pref Stock$0$0$0$0
Common Stock$118$102$94$84
Retained Earnings-$2,701,764-$2,112,238-$1,585,994-$1,207,620
AOCI$2,398-$10-$3,590-$869
Other Equity$2,563,876$1,725,823$1,481,590$1,452,268
Total Equity-$135,372-$386,323-$107,900$243,863
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,401,673$824,316$1,014,775$841,319
Net Debt$693,820$642,747$684,718$157,264